SEC
Filings

SEC Filings

SEC Filings

Filing date	Form	Description	Filing Group	View
Dec 14, 2009	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001104659-09-069830.pdf 0001104659-09-069830.rtf 0001104659-09-069830.xls
Dec 14, 2009	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001104659-09-069905.pdf 0001104659-09-069905.rtf 0001104659-09-069905.xls
Dec 14, 2009	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001104659-09-069912.pdf 0001104659-09-069912.rtf 0001104659-09-069912.xls
Dec 09, 2009	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001104659-09-069184.pdf 0001104659-09-069184.rtf 0001104659-09-069184.xls
Dec 08, 2009	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001104659-09-068961.pdf 0001104659-09-068961.rtf 0001104659-09-068961.xls
Dec 08, 2009	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001104659-09-069018.pdf 0001104659-09-069018.rtf 0001104659-09-069018.xls
Nov 25, 2009	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Registration Statements	View HTML 0001104659-09-067153.pdf 0001104659-09-067153.rtf 0001104659-09-067153.xls
Nov 25, 2009	EFFECT	EFFECT	Other	View HTML 9999999995-09-003296.pdf 9999999995-09-003296.rtf 9999999995-09-003296.xls
Nov 24, 2009	CORRESP	CORRESP	Other	View HTML 0001104659-09-066760.pdf 0001104659-09-066760.rtf 0001104659-09-066760.xls
Nov 20, 2009	S-3/A	Pre-effective amendment to an S-3 filing	Registration Statements	View HTML 0001104659-09-066041.pdf 0001104659-09-066041.rtf 0001104659-09-066041.xls

Data provided by Kaleidoscope.

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

© 2024 Altimmune. All rights reserved.